WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Houte Hans VanChief Financial Officer2024-02-166,812$10.02
$68.22kSell
Christine RingChief Legal Officer2024-01-301,760$7.99
$14.06kSell
Houte Hans VanChief Financial Officer2024-01-301,671$7.99
$13.35kSell
Gwenn HansenChief Scientific Officer2024-01-302,334$7.99
$18.65kSell
Houte Hans VanChief Financial Officer2023-12-203,541$10.00
$35.42kSell
Houte Hans VanChief Financial Officer2023-12-1910,906$10.00
$109.09kSell
Christine RingChief Legal Officer2023-10-311,232$5.20
$6.40kSell
Gwenn HansenChief Scientific Officer2023-10-311,633$5.20
$8.49kSell
Houte Hans VanChief Financial Officer2023-10-311,080$5.20
$5.61kSell
Christine RingGeneral Counsel2023-07-311,420$9.66
$13.71kSell

1 of 2

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.45%4,643,736$63.06MInstitution
Baker Bros Advisors LP7.90%3,882,125$52.72MInstitution
Third Rock Ventures Iii LP7.14%3,509,348$47.66MInsider
Redmile Group LLC6.63%3,256,519$44.22MInstitution
Ark Investment Management LLC6.50%3,194,999$43.39MInstitution
Morgan Stanley6.38%3,135,037$42.57MInstitution
Deep Track Capital LP6.10%2,997,830$40.71MInstitution
Wasatch Advisors LP5.59%2,749,745$37.34MInstitution
Vanguard Group Inc5.29%2,598,097$35.28MInstitution
Price T Rowe Associates Inc4.86%2,389,966$32.46MInstitution

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX84.44%15.56%Net SellingNet Selling
DNTH24.91%75.09%Net Buying
RGNX76.15%23.85%Net SellingNet Buying
YMAB46.22%39.32%Net BuyingNet Selling
CGEM48.26%51.74%Net SellingNet Buying
View Top Biotech Stocks

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 93.55% institutional shareholders, 17.23% Nurix Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures Iii LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 7.14% of the company. Third Rock Ventures Iii LP's Nurix Therapeutics shares are currently valued at $49.59M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.